METROPOLITAN LIFE INSURANCE CO/NY - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$9,428
-53.7%
2,7730.0%0.00%
-100.0%
Q2 2023$20,382
-9.2%
2,773
+28.0%
0.00%0.0%
Q1 2023$22,450
-37.1%
2,167
-28.3%
0.00%
-50.0%
Q4 2022$35,678
-43.7%
3,0210.0%0.00%
-33.3%
Q3 2022$63,411
-32.4%
3,0210.0%0.00%
-25.0%
Q2 2022$93,772
-24.4%
3,0210.0%0.00%0.0%
Q1 2022$124,042
-78.2%
3,021
-76.9%
0.00%
-50.0%
Q4 2021$569,327
-45.5%
13,097
-37.3%
0.01%
-46.7%
Q3 2021$1,045,061
-19.2%
20,872
+1.7%
0.02%
-16.7%
Q2 2021$1,293,311
-29.2%
20,532
+4.4%
0.02%
-33.3%
Q1 2021$1,827,911
+3.6%
19,674
-0.1%
0.03%
+3.8%
Q4 2020$1,764,493
-16.3%
19,693
-3.5%
0.03%
-29.7%
Q3 2020$2,108,655
+94.4%
20,407
+48.8%
0.04%
+94.7%
Q2 2020$1,084,819
+36.7%
13,7180.0%0.02%
+11.8%
Q1 2020$793,723
+2.8%
13,718
-4.1%
0.02%
+30.8%
Q4 2019$771,863
+0.8%
14,307
-2.3%
0.01%0.0%
Q3 2019$765,850
+8.2%
14,6490.0%0.01%
+8.3%
Q2 2019$707,693
-4.4%
14,6490.0%0.01%
-7.7%
Q1 2019$740,067
-14.8%
14,6490.0%0.01%
-23.5%
Q4 2018$868,393
-8.9%
14,649
+1.1%
0.02%0.0%
Q3 2018$953,548
-99.9%
14,4850.0%0.02%
+41.7%
Q2 2018$731,347,000
+28.7%
14,485
+34.3%
0.01%
+50.0%
Q1 2018$568,041,000
+115590.6%
10,789
+2.0%
0.01%
+14.3%
Q4 2017$491,000
-47.9%
10,574
-54.6%
0.01%
+16.7%
Q3 2017$942,000
+19.4%
23,2800.0%0.01%
+20.0%
Q2 2017$789,000
+16.7%
23,2800.0%0.01%0.0%
Q1 2017$676,000
-11.6%
23,2800.0%0.01%0.0%
Q4 2016$765,000
+4.2%
23,2800.0%0.01%0.0%
Q3 2016$734,000
+12.1%
23,2800.0%0.01%0.0%
Q2 2016$655,000
-21.6%
23,280
+1.4%
0.01%
-16.7%
Q1 2016$835,000
-9.1%
22,9660.0%0.01%
-14.3%
Q4 2015$919,000
+56.0%
22,966
+11.2%
0.01%
+75.0%
Q3 2015$589,000
-13.5%
20,6590.0%0.00%
-20.0%
Q2 2015$681,000
+11.6%
20,659
-2.7%
0.01%
+25.0%
Q1 2015$610,000
-1.6%
21,224
-6.8%
0.00%0.0%
Q4 2014$620,000
+37.8%
22,778
+7.8%
0.00%
+33.3%
Q3 2014$450,000
-5.3%
21,1380.0%0.00%0.0%
Q2 2014$475,000
-11.0%
21,1380.0%0.00%
-25.0%
Q1 2014$534,000
+9.9%
21,1380.0%0.00%
+33.3%
Q4 2013$486,000
+12.8%
21,138
-6.6%
0.00%0.0%
Q3 2013$431,000
+41.3%
22,624
+7.0%
0.00%
+50.0%
Q2 2013$305,00021,1380.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders